Breaking Through Impossible
What does it take to solve some of the greatest health and environmental challenges of our time? Leaps by Bayer, the impact investment unit of Bayer AG, drives groundbreaking technologies in life sciences to fundamentally improve humanity’s well-being.
At the heart of Leaps by Bayer’s mission are ten ambitious goals—the “10 Leaps”—that form the foundation of its investment strategy.
In health, Leaps aims for breakthrough solutions that elevate healthcare to a new level, with the goal of not just treating but curing or even preventing diseases. In agriculture, Leaps promotes innovations that help feed a growing population without further straining the environment and even contribute to the planet’s regeneration over the long term.
The 10 Leaps
- Cure genetic diseases
- Provide sustainable organ & tissue replacement
- Reduce environmental impact of agriculture
- Prevent and cure cancer
- Protect brain and mind
- Reverse autoimmune diseases and chronic inflammation
- Provide next generation healthy crops
- Develop sustainable protein supply
- Prevent crop and food loss
- Transform health with data
To achieve the impossible, teamwork is essential. In Chapter III – Leap Forward, Leaps by Bayer brings together leading figures from science and sports to embark on a journey into the future. Their achievements show how collaboration can pave the way toward tomorrow.
Collaborating with the most visionary founders in the industry
Leaps partners with some of the brightest minds in biotechnology, agriculture, and healthcare. Leaps invests in established companies or co-found new ventures with partners, providing extensive early-stage funding and access to the technical capabilities and 150 years of experience within Bayer’s network. This unique approach allows start-up companies to focus on the long-term realization of their breakthrough technologies.
Since 2015, Leaps has invested over $1.9 billion in more than 60 companies working on disruptive innovations.
COR-OTH-CH-0048-1 2411